Checkpoint molecule PD-1-assisted CD8(+) T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

PURPOSE: The aim of this study was to determine whether CD8(+) T lymphocyte and its checkpoint-associated module programmed cell death protein 1 (PD-1)/main ligand of PD-1 (PD-L1) pathway impact overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) treated with tyrosine kinas...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jiaxi, Xi, Wei, Zhu, Yanjun, Wang, Hang, Hu, Xiaoyi, Guo, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138960/
https://www.ncbi.nlm.nih.gov/pubmed/30237743
http://dx.doi.org/10.2147/CMAR.S172039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138960/
https://www.ncbi.nlm.nih.gov/pubmed/30237743
http://dx.doi.org/10.2147/CMAR.S172039

Ejemplares similares